Patterson Companies, Inc. PDCO
We take great care to ensure that the data presented and summarized in this overview for PATTERSON COMPANIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PDCO
View all-
Black Rock Inc. New York, NY12.9MShares$277 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.36MShares$201 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.98MShares$85.6 Million0.02% of portfolio
-
State Street Corp Boston, MA3.23MShares$69.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$57.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.42MShares$52.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.18MShares$46.9 Million0.03% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$46.9 Million0.08% of portfolio
-
River Road Asset Management, LLC1.99MShares$42.7 Million0.61% of portfolio
-
Geode Capital Management, LLC Boston, MA1.89MShares$40.6 Million0.0% of portfolio
Latest Institutional Activity in PDCO
Top Purchases
Top Sells
About PDCO
Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Insider Transactions at PDCO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 12
2024
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
939
-0.59%
|
$18,780
$20.76 P/Share
|
Nov 12
2024
|
Les B Korsh CLO & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-1.01%
|
$21,040
$20.76 P/Share
|
Sep 30
2024
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.04%
|
$162
$18.56 P/Share
|
Sep 16
2024
|
Pamela J Tomczik |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+50.0%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Neil A Schrimsher |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+13.81%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Philip Mc Koy |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+30.15%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Robert Frenzel |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+16.98%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Jody H Feragen |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+12.04%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
John D Buck |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+7.77%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Alex N Blanco |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+15.92%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Meenu Agarwal |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+37.95%
|
$164,220
$21.74 P/Share
|
Jul 16
2024
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
7,216
-3.04%
|
$173,184
$24.99 P/Share
|
Jul 03
2024
|
Les B Korsh CLO & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
2,842
-2.67%
|
$65,366
$23.71 P/Share
|
Jul 03
2024
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
5,875
-2.42%
|
$135,125
$23.71 P/Share
|
Jul 03
2024
|
Kevin Michael Barry CFO |
SELL
Open market or private sale
|
Direct |
1,216
-2.84%
|
$27,968
$23.72 P/Share
|
Jul 03
2024
|
Samantha L Bergeson CHRO |
SELL
Open market or private sale
|
Direct |
254
-1.22%
|
$5,842
$23.87 P/Share
|
Jul 01
2024
|
Donald Zurbay President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
110,450
+18.7%
|
$2,650,800
$24.08 P/Share
|
Jul 01
2024
|
Donald Zurbay President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,210
-3.11%
|
$221,040
$24.08 P/Share
|
Jul 01
2024
|
Kevin M Pohlman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,133
+11.11%
|
$939,192
$24.08 P/Share
|
Jul 01
2024
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,915
-1.15%
|
$69,960
$24.08 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 278K shares |
---|
Payment of exercise price or tax liability | 27.9K shares |
---|---|
Open market or private sale | 19.8K shares |